NASDAQ
SOPH

Sophia Genetics SA

Health Information Services
Healthcare

Prices are adjusted according to historical splits.

Sophia Genetics SA Stock Price

Vitals

Today's Low:
$2.4597
Today's High:
$2.55
Open Price:
$2.46
52W Low:
$1.685
52W High:
$5.77
Prev. Close:
$2.45
Volume:
8121

Company Statistics

Market Cap.:
$158.03 million
Book Value:
2.64
Revenue TTM:
$54.05 million
Operating Margin TTM:
-144.28%
Gross Profit TTM:
$31.25 million
Profit Margin:
-145%
Return on Assets TTM:
-19.48%
Return on Equity TTM:
-39.21%

Company Profile

Sophia Genetics SA had its IPO on 2021-07-23 under the ticker symbol SOPH.

The company operates in the Healthcare sector and Health Information Services industry. Sophia Genetics SA has a staff strength of 466 employees.

Stock update

Shares of Sophia Genetics SA opened at $2.46 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $2.46 - $2.55, and closed at $2.52.

This is a +2.86% increase from the previous day's closing price.

A total volume of 8,121 shares were traded at the close of the day’s session.

In the last one week, shares of Sophia Genetics SA have increased by +3.7%.

Sophia Genetics SA's Key Ratios

Sophia Genetics SA has a market cap of $158.03 million, indicating a price to book ratio of 0.7017 and a price to sales ratio of 3.3164.

In the last 12-months Sophia Genetics SA’s revenue was $54.05 million with a gross profit of $31.25 million and an EBITDA of $-75591000. The EBITDA ratio measures Sophia Genetics SA's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Sophia Genetics SA’s operating margin was -144.28% while its return on assets stood at -19.48% with a return of equity of -39.21%.

In Q2, Sophia Genetics SA’s quarterly earnings growth was a positive 0% while revenue growth was a positive 29%.

Sophia Genetics SA’s PE and PEG Ratio

Forward PE
0
Trailing PE
0
PEG

Its diluted EPS in the last 12-months stands at $-1.19 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Sophia Genetics SA’s profitability.

Sophia Genetics SA stock is trading at a EV to sales ratio of 0.1242 and a EV to EBITDA ratio of 0.3174. Its price to sales ratio in the trailing 12-months stood at 3.3164.

Sophia Genetics SA stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$223.20 million
Total Liabilities
$31.55 million
Operating Cash Flow
$0
Capital Expenditure
$3.15 million
Dividend Payout Ratio
0%

Sophia Genetics SA ended 2024 with $223.20 million in total assets and $0 in total liabilities. Its intangible assets were valued at $223.20 million while shareholder equity stood at $171.70 million.

Sophia Genetics SA ended 2024 with $0 in deferred long-term liabilities, $31.55 million in other current liabilities, 4048000.00 in common stock, $-339899000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $148.55 million and cash and short-term investments were $148.55 million. The company’s total short-term debt was $3,466,000 while long-term debt stood at $0.

Sophia Genetics SA’s total current assets stands at $168.57 million while long-term investments were $0 and short-term investments were $0.00. Its net receivables were $9.85 million compared to accounts payable of $6.55 million and inventory worth $5.46 million.

In 2024, Sophia Genetics SA's operating cash flow was $0 while its capital expenditure stood at $3.15 million.

Comparatively, Sophia Genetics SA paid $0 in dividends in 2024.

Other key metrics

Current Trading Price
$2.52
52-Week High
$5.77
52-Week Low
$1.685
Analyst Target Price
$7

Sophia Genetics SA stock is currently trading at $2.52 per share. It touched a 52-week high of $5.77 and a 52-week low of $5.77. Analysts tracking the stock have a 12-month average target price of $7.

Its 50-day moving average was $3.36 and 200-day moving average was $3.54 The short ratio stood at 0.5 indicating a short percent outstanding of 0%.

Around 484.8% of the company’s stock are held by insiders while 5247.4% are held by institutions.

Frequently Asked Questions About Sophia Genetics SA

The stock symbol (also called stock or share ticker) of Sophia Genetics SA is SOPH

The IPO of Sophia Genetics SA took place on 2021-07-23

Similar Industry Stocks (Health Information Services)

Last Price
Chg
Chg%
$82.12
-3.88
-4.51%
$85.72
0.6
+0.7%
$6.14
0
0%
Indiva Ltd (NDVAF)
$0.04
0
0%
Flex Ltd (FLEX)
$26.3
-0.2
-0.75%
$25.1
-0.16
-0.63%
Divyashakti Ltd (DIVSHKT)
$76.06
-3.18
-4.01%
$35.49
-1.55
-4.18%
$272.2
-4.4
-1.59%
$5.11
-2.89
-36.13%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
$0.14
0.07
+100%
$0.12
0.04
+45.29%
$0.96
0.05
+5.4%
$1.34
-0.35
-20.71%
Humbl Inc (HMBL)
$0
0
0%

Top Gainers

Last Price
Chg
Chg%
$0
0
+172200%
$0
0
+51200%
$283
280.03
+9428.62%
$11.2
10.57
+1667.68%
Latch Inc (LTCHW)
$0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
$0.19
-123.15
-99.85%
$0
-0.11
-99.55%
$0
-0
-97.96%
$0
-0.01
-93.94%
$0.01
-0.06
-92.24%

About

SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. The company offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharma customers worldwide. The company was incorporated in 2011 and is headquartered in Saint-Sulpice, Switzerland.

Address

Rue du Centre 172, Saint-Sulpice, Switzerland, 1025